Insiders · Profile

SPIEGELMAN DANIEL K

Director at MYRIAD GENETICS · EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL. Filing since 1 May 2013. CIK 0001238403

Company
Date
Role
Action
Shares
Amount
Of holding
4 Jun 2024
Director
Sold on a plan
3,788
$83.53K
10.3%
3 Jun 2024
Director
Sold on a plan
3,788
$83.49K
9.4%
2 Jun 2023
Director
Sold at will
8,638
$198.76K
17.6%
6 Jun 2022
Director
Sold, plan not stated
6,424
$123.67K
15.9%
17 Jun 2021
Director
Sold, plan not stated
3,139
$95.79K
11.9%
28 May 2021
Director
Sold, plan not stated
7,142
$207.02K
34.7%
1 Apr 2019
EVP, Chief Financial Officer
Sold, plan not stated
13,473
$1.20M
22.1%
27 Mar 2019
EVP, Chief Financial Officer
Sold, plan not stated
100
$9.00K
0.2%
22 Jun 2018
EVP, Chief Financial Officer
Sold, plan not stated
10,000
$990.00K
16.4%
23 Apr 2018
EVP, Chief Financial Officer
Sold, plan not stated
11,059
$908.50K
15.0%
16 Mar 2017
EVP, Chief Financial Officer
Sold, plan not stated
1,989
$182.91K
12.1%
6 Mar 2017
EVP, Chief Financial Officer
Sold, plan not stated
2,303
$214.92K
10.0%
1 Mar 2017
EVP, Chief Financial Officer
Sold, plan not stated
5,000
$472.50K
16.5%
28 Feb 2017
EVP, Chief Financial Officer
Sold, plan not stated
30,000
$2.82M
49.7%
9 Jan 2017
EVP, Chief Financial Officer
Sold, plan not stated
5,000
$450.00K
21.6%
9 Nov 2016
EVP, Chief Financial Officer
Sold, plan not stated
20,000
$1.81M
46.4%
1 Aug 2016
EVP, Chief Financial Officer
Sold, plan not stated
4,000
$397.32K
8.5%
6 Jun 2016
EVP, Chief Financial Officer
Sold, plan not stated
1,649
$146.99K
3.4%
31 May 2016
EVP, Chief Financial Officer
Sold, plan not stated
20,841
$1.87M
29.3%
23 May 2016
EVP, Chief Financial Officer
Sold, plan not stated
3,769
$328.18K
6.0%
2 Mar 2016
EVP, Chief Financial Officer
Sold, plan not stated
4,623
$398.12K
8.5%
16 Nov 2015
EVP, Chief Financial Officer
Sold, plan not stated
20,000
$2.09M
41.5%
5 Jun 2015
EVP, Chief Financial Officer
Sold, plan not stated
1,649
$201.67K
5.5%
1 Jun 2015
EVP, Chief Financial Officer
Sold, plan not stated
3,945
$489.81K
11.1%
29 May 2015
EVP, Chief Financial Officer
Sold, plan not stated
1,578
$199.07K
4.2%
18 May 2015
EVP, Chief Financial Officer
Sold, plan not stated
34,078
$4.43M
45.1%
18 May 2015
EVP, Chief Financial Officer
Bought
2,059
$256.90K
2.8%
2 Mar 2015
EVP, Chief Financial Officer
Sold, plan not stated
15,500
$1.66M
18.4%
3 Sep 2014
EVP, Chief Financial Officer
Sold, plan not stated
18
$1.26K
0.0%
2 Sep 2014
EVP, Chief Financial Officer
Sold, plan not stated
16,000
$1.12M
18.9%
1 Aug 2014
EVP, Chief Financial Officer
Sold, plan not stated
2,229
$137.65K
3.1%
2 Jul 2014
EVP, Chief Financial Officer
Sold, plan not stated
2,229
$142.66K
3.0%
2 May 2014
EVP, Chief Financial Officer
Sold, plan not stated
11
$644.31
0.0%
5 Mar 2014
EVP, Chief Financial Officer
Sold, plan not stated
12
$995.11
0.0%
3 Mar 2014
EVP, Chief Financial Officer
Sold, plan not stated
8,000
$642.53K
11.1%
2 Dec 2013
EVP, Chief Financial Officer
Sold, plan not stated
9,000
$631.27K
19.2%
4 Sep 2013
EVP, Chief Financial Officer
Sold, plan not stated
9,000
$621.00K
19.2%
1 Jul 2013
EVP, Chief Financial Officer
Sold, plan not stated
4,066
$243.06K
9.7%
1 May 2013
EVP, Chief Financial Officer
Sold, plan not stated
28,000
$1.80M
45.9%
39 decisions on file.